Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGM ˙ US91864C1071

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Karen A Dawes. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Karen A Dawes har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:RGEN / Repligen Corporation Director 92.096
US:VACC / Vaccitech plc - ADR Director 1.700
US:04545LAA5 / Assertio Therapeutics Inc 5% 08/15/2024 CNV 144A Director 84.589
US:69329YAE4 / PDL BioPharma, Inc. Bond 2.875% Director 2.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Karen A Dawes. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-05-04 VACC DAWES KAREN A 1.700 17,0000 1.700 17,0000 28.900 13 17 0 0,00

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Insidersalg BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Karen A Dawes som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-05-19 2025-05-15 4 RGEN REPLIGEN CORP
Common Stock
A - Award 973 92.096 1,07
2024-06-14 2024-06-14 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2.953 88.170 3,47 67,71 199.948 5.969.991
2024-05-20 2024-05-16 4 RGEN REPLIGEN CORP
Common Stock
A - Award 803 88.170 0,92
2024-02-28 2024-02-27 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1.000 87.367 -1,13 193,35 -193.350 16.892.409
2024-02-28 2024-02-27 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 4.626 88.367 5,52 42,07 194.616 3.717.600
2023-08-30 2023-08-29 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -850 83.741 -1,00 171,38 -145.673 14.351.533
2023-08-30 2023-08-29 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 7.392 84.591 9,58 18,12 133.943 1.532.789
2023-05-22 2023-05-18 4 RGEN REPLIGEN CORP
Common Stock
A - Award 798 77.199 1,04
2022-09-09 2022-09-09 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -775 76.401 -1,00 227,17 -176.057 17.356.015
2022-05-31 2022-05-26 4 RGEN REPLIGEN CORP
Common Stock
A - Award 644 77.176 0,84
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -742 76.532 -0,96 152,84 -113.407 11.697.151
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1.875 77.274 -2,37 152,14 -285.262 11.756.466
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1.845 79.149 -2,28 151,14 -278.853 11.962.580
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -7.677 80.994 -8,66 150,19 -1.153.009 12.164.489
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2.576 88.671 -2,82 149,18 -384.288 13.227.940
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 4.783 0 -100,00
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -14 91.247 -0,02 271,28 -3.798 24.753.486
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -255 91.261 -0,28 269,94 -68.835 24.634.994
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -349 91.516 -0,38 267,75 -93.445 24.503.409
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -486 91.865 -0,53 266,72 -129.626 24.502.233
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -488 92.351 -0,53 265,27 -129.452 24.497.950
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -336 92.839 -0,36 264,21 -88.775 24.528.992
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1.119 93.175 -1,19 263,23 -294.554 24.526.455
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1.038 94.294 -1,09 262,28 -272.247 24.731.430
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -236 95.332 -0,25 261,10 -61.620 24.891.185
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -462 95.568 -0,48 259,75 -120.004 24.823.788
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise -4.783 96.030 -4,74 26,12 -124.932 2.508.304
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -283 91.247 -0,31 306,49 -86.737 27.966.293
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -700 91.530 -0,76 305,91 -214.137 27.999.942
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -124 92.230 -0,13 304,23 -37.725 28.059.133
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -532 92.354 -0,57 303,48 -161.451 28.027.592
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -446 92.886 -0,48 301,97 -134.679 28.048.785
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -251 93.332 -0,27 301,20 -75.601 28.111.598
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -64 93.583 -0,07 299,02 -19.137 27.983.189
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -27 93.647 -0,03 295,82 -7.987 27.702.656
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -108 93.674 -0,12 295,02 -31.862 27.635.703
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -101 93.782 -0,11 294,06 -29.700 27.577.535
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -25 93.883 -0,03 292,34 -7.308 27.445.756
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -13 93.908 -0,01 290,02 -3.770 27.235.198
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 3.459 0 -100,00
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -851 93.921 -0,90 285,44 -242.909 26.808.810
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1.107 94.772 -1,15 284,64 -315.096 26.975.902
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -661 95.879 -0,68 283,56 -187.433 27.187.449
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -405 96.540 -0,42 282,53 -114.425 27.275.446
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -196 96.945 -0,20 281,68 -55.209 27.307.468
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -239 97.141 -0,25 280,27 -66.985 27.225.708
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise X -3.459 97.380 -3,43 38,76 -134.071 3.774.449
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X 40 93.921 0,04 262,31 10.492 24.636.418
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -78 93.961 -0,08 260,91 -20.351 24.515.365
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -388 94.039 -0,41 259,93 -100.853 24.443.557
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -634 94.427 -0,67 258,91 -164.149 24.448.095
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -302 95.061 -0,32 257,66 -77.813 24.493.417
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -194 95.363 -0,20 256,43 -49.747 24.453.934
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2.231 95.557 -2,28 255,07 -569.061 24.373.724
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -8.580 97.788 -8,07 254,09 -2.180.092 24.846.953
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -4.665 106.368 -4,20 253,34 -1.181.831 26.947.269
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -920 111.033 -0,82 251,92 -231.766 27.971.433
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -924 111.953 -0,82 251,15 -232.063 28.116.996
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 2.929 0 -100,00
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -5 117.462 0,00 204,02 -1.020 23.964.597
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -444 117.467 -0,38 203,09 -90.172 23.856.373
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -630 117.911 -0,53 202,29 -127.443 23.852.216
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -441 118.541 -0,37 201,27 -88.760 23.858.747
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
M - Exercise 2.929 118.982 2,52 41,19 120.646 4.900.869
2021-07-22 2021-07-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -614 112.877 -0,54 203,11 -124.710 22.926.447
2021-07-22 2021-07-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2.877 113.491 -2,47 202,29 -581.988 22.958.094
2021-07-22 2021-07-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -806 116.368 -0,69 201,37 -162.304 23.433.024
2021-07-22 2021-07-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -288 117.174 -0,25 200,01 -57.603 23.435.972
2021-07-15 2021-07-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 2.929 0 -100,00
2021-07-15 2021-07-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale 1.520 117.462 1,31 202,23 307.390 23.754.340
2021-07-15 2021-07-13 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2.929 118.982 2,52 41,19 120.646 4.900.869
2021-05-17 2021-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 1.522 1.522
2021-05-17 2021-05-13 4 RGEN REPLIGEN CORP
Common Stock
A - Award 604 116.053 0,52
2021-05-13 2021-05-11 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -15.000 0 -100,00
2021-05-13 2021-05-11 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -285 115.449 -0,25 176,85 -50.402 20.417.156
2021-05-13 2021-05-11 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 15.000 115.734 14,89 3,22 48.300 372.663
2021-05-06 2021-05-04 4 VACC Vaccitech plc
Ordinary Shares
P - Purchase 1.700 1.700 17,00 28.900 28.900
2021-05-04 2021-04-29 4 VACC Vaccitech plc
Share Option (Right to Buy)
A - Award 34.328 34.328
2020-06-22 2020-06-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2.568 100.734 -2,49 116,56 -299.326 11.741.555
2020-06-22 2020-06-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -8.217 103.302 -7,37 115,76 -951.200 11.958.240
2020-06-22 2020-06-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -5.243 111.519 -4,49 114,49 -600.271 12.767.810
2020-06-22 2020-06-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2.677 116.762 -2,24 113,58 -304.054 13.261.828
2020-05-21 2020-05-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -182 119.439 -0,15 140,29 -25.533 16.756.097
2020-05-21 2020-05-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -282 119.621 -0,24 139,40 -39.311 16.675.167
2020-05-21 2020-05-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -43 119.903 -0,04 136,98 -5.890 16.424.313
2020-05-21 2020-05-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -10 119.946 -0,01 135,91 -1.359 16.301.861
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -80 119.956 -0,07 142,45 -11.396 17.087.732
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -77 120.036 -0,06 141,45 -10.892 16.979.092
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -180 120.113 -0,15 140,62 -25.312 16.890.290
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -122 120.293 -0,10 139,32 -16.997 16.759.221
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -269 120.415 -0,22 138,60 -37.283 16.689.519
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -160 120.684 -0,13 136,92 -21.907 16.524.053
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -712 120.844 -0,59 135,76 -96.661 16.405.781
2020-05-21 2020-05-13 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 1.761 1.761
2020-05-21 2020-05-13 4/A RGEN REPLIGEN CORP
Common Stock
A - Award 722 121.556 0,60
2020-05-21 2020-04-21 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -11.800 0 -100,00
2020-05-21 2020-04-21 4/A RGEN REPLIGEN CORP
Common Stock
M - Exercise 11.800 120.834 10,82 3,30 38.940 398.752
2020-05-21 2020-04-20 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -8.200 11.800 -41,00
2020-05-21 2020-04-20 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -8.998 109.034 -7,62 104,42 -939.571 11.385.330
2020-05-21 2020-04-20 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -3.202 118.032 -2,64 104,98 -336.146 12.390.999
2020-05-21 2020-04-20 4/A RGEN REPLIGEN CORP
Common Stock
M - Exercise 8.200 121.234 7,25 3,30 27.060 400.072
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -80 119.956 -0,07 142,45 -11.396 17.087.732
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -77 120.036 -0,06 141,45 -10.892 16.979.092
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -180 120.113 -0,15 140,62 -25.312 16.890.290
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -122 120.293 -0,10 139,32 -16.997 16.759.221
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -269 120.415 -0,22 138,60 -37.283 16.689.519
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -160 120.684 -0,13 136,92 -21.907 16.524.053
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -712 120.844 -0,59 135,76 -96.661 16.405.781
2020-05-19 2020-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 1.761 1.761
2020-05-19 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
A - Award 722 121.556 0,60
2020-05-11 2020-05-08 4 ASRT Assertio Therapeutics, Inc
Common Stock
S - Sale X -15.834 84.589 -15,77 0,79 -12.531 66.944
2020-04-22 2020-04-21 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -11.800 0 -100,00
2020-04-22 2020-04-21 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 11.800 120.834 10,82 3,30 38.940 398.752
2020-04-22 2020-04-20 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -8.200 11.800 -41,00
2020-04-22 2020-04-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -8.998 109.034 -7,62 104,42 -939.571 11.385.330
2020-04-22 2020-04-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -3.202 118.032 -2,64 104,98 -336.146 12.390.999
2020-04-22 2020-04-20 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 8.200 121.234 7,25 3,30 27.060 400.072
2020-02-24 2020-02-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1.849 113.034 -1,61 97,52 -180.314 11.023.076
2020-02-24 2020-02-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -906 114.883 -0,78 99,12 -89.803 11.387.203
2020-02-24 2020-02-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -945 115.789 -0,81 99,85 -94.358 11.561.532
2020-02-24 2020-02-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -300 116.734 -0,26 101,06 -30.318 11.797.138
2019-06-19 2019-06-17 4 RGEN REPLIGEN CORP
Stock Options (Right to Buy)
M - Exercise -20.000 0 -100,00
2019-06-19 2019-06-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1.295 117.034 -1,09 77,35 -100.168 9.052.580
2019-06-19 2019-06-17 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 20.000 118.329 20,34 4,96 99.200 586.912
2019-06-14 2019-06-13 4 ASRT Assertio Therapeutics, Inc
Common Stock
S - Sale X -12.500 100.423 -11,07 3,18 -39.794 319.697
2019-05-17 2019-05-15 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 2.953 2.953
2019-05-17 2019-05-15 4 RGEN REPLIGEN CORP
Common Stock
A - Award 1.292 98.329 1,33
2019-05-09 2019-05-08 4 ASRT Assertio Therapeutics, Inc
Restricted Stock Units
M - Exercise -31.250 0 -100,00
2019-05-09 2019-05-08 4 ASRT Assertio Therapeutics, Inc
Common Stock
M - Exercise 31.250 112.923 38,26
2019-05-09 2019-05-07 4 ASRT Assertio Therapeutics, Inc
Common Stock
A - Award 39.584 81.673 94,05
2018-12-04 2018-12-03 4 ASRT Assertio Therapeutics, Inc
Stock Option
M - Exercise -15.000 0 -100,00
2018-12-04 2018-12-03 4 ASRT Assertio Therapeutics, Inc
Common Stock
S - Sale -8.421 42.089 -16,67 4,84 -40.725 203.547
2018-12-04 2018-12-03 4 ASRT Assertio Therapeutics, Inc
Common Stock
M - Exercise 15.000 50.510 42,24 1,49 22.350 75.260
2018-05-17 2018-05-16 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 4.626 4.626
2018-05-17 2018-05-16 4 RGEN REPLIGEN CORP
Common Stock
A - Award 2.080 97.037 2,19
2018-05-15 2018-05-11 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2018-05-15 2018-05-11 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -20.000 94.957 -17,40 41,80 -835.936 3.968.899
2018-05-15 2018-05-11 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 20.000 114.957 21,06 5,08 101.600 583.982
2018-05-10 2018-05-08 4 DEPO DEPOMED INC
Restricted Stock Units
A - Award 31.250 31.250
2017-08-16 2017-08-15 4 DEPO DEPOMED INC
Restricted Stock Units
A - Award 19.512 19.512
2017-05-22 2017-05-18 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 3.459 3.459
2017-05-22 2017-05-18 4 RGEN REPLIGEN CORP
Common Stock
A - Award 1.714 94.957 1,84
2017-03-22 2017-03-21 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2017-03-22 2017-03-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -2.521 93.243 -2,63 34,12 -86.017 3.181.460
2017-03-22 2017-03-21 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 20.000 95.764 26,40 4,29 85.800 410.828
2016-07-15 2016-07-14 4 RGEN REPLIGEN CORP
Common Stock
A - Award 20.000 75.764 35,87
2016-06-28 2016-06-27 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -15.000 0 -100,00
2016-06-28 2016-06-27 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -1.982 55.764 -3,43 23,46 -46.498 1.308.223
2016-06-28 2016-06-27 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 15.000 57.746 35,09 3,10 46.500 179.013
2016-05-20 2016-05-18 4 DEPO DEPOMED INC
Restricted Stock Units
A - Award 3.131 3.131
2016-05-20 2016-05-18 4 DEPO DEPOMED INC
Stock Options
A - Award 7.669 7.669
2016-05-13 2016-05-11 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 4.783 4.783
2016-05-13 2016-05-11 4 RGEN REPLIGEN CORP
Common Stock
A - Award 2.505 42.746 6,22
2016-05-13 2016-05-12 4 DEPO DEPOMED INC
Common Stock
F - Taxes -734 12.867 -5,40 17,52 -12.860 225.430
2015-12-03 2015-12-01 4 DEPO DEPOMED INC
Common Stock
F - Taxes -1.198 10.665 -10,10 19,00 -22.762 202.635
2015-11-12 2015-11-10 4 RGEN REPLIGEN CORP
Common Stock
A - Award 1.000 40.241 2,55 26,70 26.700 1.074.435
2015-05-26 2015-05-21 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 2.929 2.929
2015-05-26 2015-05-21 4 RGEN REPLIGEN CORP
Common Stock
A - Award 1.498 39.241 3,97
2015-05-13 2015-05-12 4 DEPO DEPOMED INC
Restricted Stock Unit
A - Award 2.936 2.936
2015-05-13 2015-05-12 4 DEPO DEPOMED INC
Stock Option
A - Award 7.857 7.857
2014-12-12 2014-12-01 4 DEPO DEPOMED INC
Restricted Stock Unit
A - Award 3.863 3.863
2014-12-12 2014-12-01 4 DEPO DEPOMED INC
Stock Option
A - Award 9.852 9.852
2014-05-19 2014-05-15 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 7.392 7.392
2014-05-19 2014-05-15 4 RGEN REPLIGEN CORP
Common Stock
A - Award 3.863 37.743 11,40
2013-12-12 2013-12-10 4 DEPO DEPOMED INC
Stock Option
A - Award 20.000 20.000
2013-06-21 2013-06-21 4 RGEN REPLIGEN CORP
Common Stock
P - Purchase 1.000 33.880 3,04 7,70 7.700 260.873
2013-05-16 2013-05-09 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5.342 32.880 19,40
2013-03-06 2013-03-06 4 DEPO DEPOMED INC
Common Stock
P - Purchase 2.000 8.000 33,33 5,96 11.920 47.680
2012-12-06 2012-12-04 4 DEPO DEPOMED INC
Stock Option
A - Award 20.000 20.000
2012-06-20 2012-05-24 4 RGEN REPLIGEN CORP
Common Stock
A - Award 11.038 27.538 66,90
2006-09-05 2006-09-01 4 RGEN REPLIGEN CORP
Common Stock
P - Purchase 2.000 2.000 3,33 6.660 6.660
2005-06-27 2005-05-24 4/A PDLI PROTEIN DESIGN LABS INC/DE
Common Stock
M - Exercise 0 2.000 0,00 13,55 27.100
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)